4 days ago Bristol-Myers Squibb Company stocks price quote with latest real-time prices, charts, financials, Earnings Estimates - Current Qtr 03/31/20. In depth view into BMY (Bristol-Myers Squibb) stock including the latest price, news, dividend history, earnings information and financials. Bristol-Myers Squibb Company. BMY. Quote. Price vs. Fair Value. Trailing Returns. Financials. Valuation. Operating Performance. Dividends. Ownership. Stockopedia rates Bristol-Myers Squibb Co as a Conservative High Flyer . 6 brokers rate it as a Price to Book Value Diluted Weighted Average Shares. m .
Bristol-Myers Squibb engages in the discovery, development, licensing, IPO Status Public Stock Symbol NYSE:BMY Company Type For Profit Bristol-Myers Squibb has 60 current team members, including Foundation President John
Nov 09, 2019 · 15 Wall Street analysts have issued ratings and price targets for Bristol-Myers Squibb in the last 12 months. Their average twelve-month price target is $64.33, suggesting that the stock has a possible upside of 15.85%. The high price target for BMY is $80.00 and the low price … Better Buy: Pfizer vs. Bristol-Myers Squibb | The Motley Fool Dec 08, 2019 · Better Buy: Pfizer vs. Bristol-Myers Squibb Which stock wins in a matchup between these two big drugmakers? Keith Speights (TMFFishBiz) Current product lineups. Bristol-myers Squibb Company - BMY - Stock Price Today - Zacks View Bristol-myers Squibb Company BMY investment & stock information. Get the latest Bristol-myers Squibb Company BMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. BMY Stock Quote - Bristol-Myers Squibb Co. Stock Price Today Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics.
BMY Stock: Is It A Buy Now? Here's What Earnings, Bristol ...
Bristol-Myers Squibb Company. BMY. Quote. Price vs. Fair Value. Trailing Returns. Financials. Valuation. Operating Performance. Dividends. Ownership. Stockopedia rates Bristol-Myers Squibb Co as a Conservative High Flyer . 6 brokers rate it as a Price to Book Value Diluted Weighted Average Shares. m . Current share price (P). No. shares of common stock outstanding. Growth rate (g). Earnings per share (EPS). Next year Bristol-Myers Squibb engages in the discovery, development, licensing, IPO Status Public Stock Symbol NYSE:BMY Company Type For Profit Bristol-Myers Squibb has 60 current team members, including Foundation President John 30 Mar 2020 analysis on Bristol-Myers Squibb Company (BMY) stock, price quote Infiniti Pharma's IPI-549 Fast Track'd for urothelial cancer; shares up 28 Feb 2020 A sum of 20529028 shares traded at recent session and its average exchanging volume remained at 14.59M shares. The 52-week price high and
BMY -- Is Its Stock Price A Worthy Investment? Learn More.
Bristol-Myers Squibb - 48 Year Stock Price History | BMY ... 50 rows · Historical daily share price chart and data for Bristol-Myers Squibb since 1972 adjusted for … Is Bristol-Myers Squibb (BMY) a Good Stock to Pick Now? Jan 17, 2020 · Bristol-Myers Squibb Company price-consensus-chart | Bristol-Myers Squibb Company Quote. This bullish trend is why the stock boasts a Zacks Rank #2 (Buy) and why we are expecting outperformance BMY: Bristol-Myers Squibb Co - Stock Price, Quote and News ... Get Bristol-Myers Squibb Co (BMY:NYSE) real-time stock quotes, news and financial information from CNBC. Use My Current Location Morgan Stanley likes Bristol-Myers Squibb in premarket Bristol-Myers Squibb Reaches Analyst Target Price | Nasdaq
Oct 31, 2019 · So, let’s discuss Bristol-Myers Squibb’s third-quarter performance, valuation, and technical chart to see if it’s worth buying BMY stock at the current levels. Bristol-Myers Squibb Q3
Three share ideas for an ISA. Discover three shares to consider for this year's allowance. See the shares. Important Documents. There are no documents
Mar 26, 2020 · Bristol-Myers Squibb (NYSE: BMY) could see a 40% upside from the current levels, per our price estimate of $68, which is based on expected 2020 earnings of $6.25 on an adjusted basis, and a price Bristol-Myers Squibb Company (BMY) picks momentum as ...